Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08
Go back to Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 35.36 +2.99 (9.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.37 | 52 Week High | $5.17 | |||
| Open | $31.76 | 52 Week Low | $0.94 | |||
| Day High | $35.69 | P/E | N/A | |||
| Day Low | $31.76 | EPS | $0.00 | |||
| Volume | 2,804,337 | |||||

